Screening for Hazardous Alcohol Use and Depressive Symptomatology Among HIV-Infected Patients in Nigeria: Prevalence,Predictors,and Association With Adherence
Screening for Hazardous Alcohol Use and Depressive Symptomatology Among HIV-Infected Patients in Nigeria: Prevalence,Predictors,and Association With Adherence
Scores from the Alcohol Use Disorders Identification Test (AUDIT) and the Center for Epidemiological Studies Depression Scale (CES-D) administered to both antiretroviral therapy (ART)-experienced and -naive adults in HIV care in Nigeria were evaluated for association with participant characteristics and ART adherence measured by pharmacy records. Participants included 222 ART-experienced and 177 ART-naive adults, of whom 47 (12%) had AUDIT ≥8, 29 (7%) an AUDIT ≥10, 52 (13%) a CES-D ≥16, and 25 (6%) a CES-D ≥21. An elevated AUDIT score was more frequent among ART-naive and men, while disclosure of HIV status to others was associated with lower scores. An elevated CES-D score was more frequent among ART-naive and those with lower educational level, while disclosure of HIV status and choosing to be interviewed in English rather than Hausa was associated with lower scores. An elevated CES-D score was associated with poor adherence.
World Health Organization.HIV/AIDS epidemiological surveillance report for the WHO African region: 2007 update. http://www.afro.who.int/aids/publications/OMS%20HIVAIDS%20in%20Africa%202007-FINAL.pdf. Accessed August 11, 2009.
2.
World Health Organization.Towards universal access: scaling up priority HIV/AIDS interventions in the health sector, progress report June 2008. http://www.who.int/hiv/pub/2008progressreport/en/index.html . Accessed August 11, 2009.
3.
Joint United Nations Programme on HIV/Aids.Country responses: Nigeria. http://www.unaids.org/en/CountryResponses/Countries/nigeria.asp . Accessed January 8, 2010.
4.
Nigerian National Agency for the Control of AIDS. Nigeria UNGASS Report, 2007. http://www.data.unaids.org/pub/Report/2008/nigeria_2008_country_progress_report_en.pdf. Accessed January 8, 2010.
5.
Mill EJ, Nachega JB, Buchan I., et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006 ;296(6):679-690.
6.
Rosen S., Fox MP, Gill CJPatient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007;4(10):e298; doi:10.1371/journal.pmed.0040298..
7.
Bell DJ, Kapitao Y., Sikwese R., van Oosterhout JJ, Lalloo DGAdherence to antiretroviral therapy in patients receiving free treatment from a government hospital in Blantyre, Malawi. J Acquir Immune Defic Syndr. 2007;45(5):560-563.
8.
Vriesendorp R., Cohen A., Kristanto P., et al. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana. Eur J Clin Pharmacol. 2007;63(12): 1115-1121.
9.
Muyingo SK, Walker AS, Reid A., et al. Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trail in Uganda and Zimbabwe. J Acquir Immune Defic Syndr . 2008; 48(4):468-475.
10.
Goldman JD, Cantrell RA, Mulaenga LB, et al. Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy. AIDS Res Hum Retroviruses. 2008;24(8):1031-1035.
11.
Chi BH, Cantrell RA, Zulu I., et al. Adherence to first line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia . Int J pidemiol.2009;38(3):746-756.
12.
Unge C., Sodergard B., Ekstrom AM, et al. Challenges for scaling up ART in a resource-limited setting: a retrospective study in Kibera, Kenya. J Acquir Immune Defic Syndr.2009;50(4):397-342.
13.
Charurat ME, Oyegunle M., Benjamin R., et al. Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors. PLoS Med. 2010; in press.
14.
Galvan FH, Bing EG, Fleishman JA, et al. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol. 2002;63(2):179-186.
15.
Kalichman SC , Simbayi LC, Kaufman M., Cain D., Jooste S.Alcohol use and sexual risks for HIV/AIDS in sub-Saharan Africa: systematic review of empirical findings. Prev Sci. 2007;8(2):141-151.
16.
Chinyadza E. , Moyo IM, Katsumbe TM, et al. Alcohol problems among patients attending five primary health care clinics in Harare City. Cent Afr J Med. 1993;39(2):26-32.
17.
Shaffer DN, Njeri R., Justice AC, Odero WW, Tierney WMAlcohol abuse among patients with and without HIV infection attending public clinics in western Kenya. East Afr Med J. 2004;81(11): 594-598.
18.
Mbulaiteye SM, Ruberantwari A., Nakiyingi JS, Carpenter LM, Kamali A., Whitworth JAAlcohol and HIV: a study among sexually active adults in rural southwest Uganda. Int J Epidemiol. 2000;29(5):911-915.
19.
Myer L., Smit J., Le Roux L., Parker S., Stein DJ, Seedat S.Common mental disorders among HIV-infected individuals in South Africa: prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient Care STDS. 2008;22(2):147-158.
20.
Chander G., Himelhoch S., Moore RDSubstance abuse and psychiatric disorders in HIV-positive patients. Drugs. 2006;66(6): 769-789.
21.
Hendershot CS, Stoner SA, Pantalone DW, Simoni JMAlcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr.2009;52(2):180-202.
22.
Rabkin JGHIV and depression: 2008 review and update. Curr HIV/AIDS Rep. 2008;5(4):163-171.
23.
Horberg MA, Silverburg MJ, Hurley LB, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008; 47(3):384-390.
24.
Yun LW, Maravi M., Kobayashi JS, Barton PL, Davidson AJAntidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr . 2005;38(4):432-438.
25.
Byakika-Tusiime J., Crane J., Oyugi JH, et al. Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining adherence over time . AIDS Behav.2009;13(suppl 1):S82-S91.
26.
Amberbir A. , Woldemichael K., Getachew S., Girma B., Deribe K.Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia . BMC Public Health. 2008;8:265. doi:10.1186/1471-2458-8-265..
27.
Saunders JB , Aasland OG, Babor TF, De la Fuente JR, Grant M.Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption II. Addiction. 1993; 88(6):791-804.
28.
Conigrave KM , Hall WD, Saunders JBThe AUDIT questionnaire: choosing a cut-off score. Addition. 1995;90(10):1349-1356.
29.
Bohn MJ, Babor TF, Kranzler HRThe alcohol use identification test (AUDIT): validation of a screening instrument for use in medical settings. J Stud Alcohol. 1994;56(4):423-432.
30.
Radloff LSThe CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977; 1(3):386-401.
31.
Poupard M., Gueye NF, Thiam D., et al. Quality of life and depression among HIV-infected patients receiving efavirenz- or protease inhibitor-based therapy in Senegal. HIV Med. 2007;8(2): 92-95.
32.
Kaharuza FM , Bunnell R., Moss S., et al. Depression and CD4 cell count among persons with HIV infection in Uganda. AIDS Behav. 2006;10(4 suppl):S105-S111.
33.
Pretorius TBCross-cultural applications of the Centre for Epidemiological Studies depression scale: a study of black South African students . Psychol Rep. 1991;69(3 pt 2):1179-1185.
34.
Wessiman MM, Prusoff B., Newberry P.Comparison of the CES-D With Standardized Depression Rating Scales at Three Points in Time. Yale University Technical Report. Yale University Press; New Haven, CT: Yale University Press; 1975.
35.
Schein RL, Roenig HGThe Center for Epidemiological Studies-Depression (CES-D) Scale: assessment of depression in the medically ill elderly. Int J Geriatr . 1997;12(4):436-446.
36.
Lyness JM, Noel TK, Cox C., King DA, Conwell Y., Caine EDScreening for depression in elderly primary care patients: a comparison of the Center for Epidemiologic Studies-Depression Scale and the Geriatric Depression Scale. Arch Intern Med. 1997;157(4):449-454.
37.
Adewuya A.Validation of the Alcohol Use Disorders Identification Test (AUDIT) as a screening tool for alcohol-related problems among Nigerian University students. Alcohol Alcohol. 2005;40(6):575-577.
38.
Gureja O., Obikoya B., Ikuesan BAAlcohol abuse and dependence in an urban primary care clinic in Nigeria. Drug Alcohol Depend. 1992;30(2):163-167.
39.
Adewuya AO, Afolabi MO, Ola BA, et al. Relationship between depression and quality of life in persons with HIV infection in Nigeria. Int J Psychiatry Med. 2008;38(1):43-51.
40.
Olley BO, Seedat S., Stein DJPersistence of psychiatric disorders in a cohort of HIV/AIDS patients in South Africa: a 6-month follow-up study. J Psychosom Res. 2006;61(4):479-484.
41.
Lima VD, Geller J., Bangsberg DR, et al. The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART . AIDS. 2007;21(9):1175-1183.
42.
Saberi P., Caswell N., Amodio-Groton M., Alpert P.Pharmacy refill measure of adherence to efavirenz can predict maintenance of HIV viral suppression. AIDS Care. 2008;20(6):741-745.
43.
Bisson GP, Gross R., Bellamy S., et al. Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy. PLoS Med. 2008; 5(5):e109.
44.
Goldman JD, Cantrell RA, Mulengta LB, et al. Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy. AIDS Res Hum Retroviruses. 2008;24(8):1031-1035.
45.
Kalichman SC , Rompa D., Cage M.Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS. J Nerv Ment Dis. 2000;188(10):662-670.
